Dataset Information

Comparative Analysis of Natural Radioactivity Content in Tiles made in Nigeria and Imported Tiles from China.

ABSTRACT: In this investigation, natural radioactive contents in tiles manufactured in Nigeria and tiles imported from China were measured using gamma ray spectroscopy. High Purity Germanium detector was used to estimate the concentrations of some radioisotopes present in 17 samples of various tiles from Nigeria and China. The average activity concentrations of ²²⁶Ra, ²³²Th, and ⁴⁰K for the tiles were found to be 68.2 ± 0.5; 173.9 ± 9.2 and 490 ± 15 Bq/kg and 58.2 ± 0.5, 161.5 ± 9.4 and 455.7 ± 15.1 Bq/kg for the tiles from Nigeria and China respectively. Radiological hazard indices such as absorbed dose rate, radium equivalent activity, external Hazard Index (H_ex), internal Hazard Index (H_in), Annual Effective Dose (mSv/y), Gamma activity Index (Iγ) and Alpha Index (Iα) were determined for both kind of tiles from Nigeria and China. The mean values obtained were: 354.56 and 317.16 Bq/kg; 169.22 nGyh^-1 and 153.92 nGyh^-1; 0.95 and 0.87; 1.14 and 1.08; 1.59 mSv/y and 1.52 mSv/y; 1 and 1.15 and; 0.34 and 0.29 respectively. The mean value of radium equivalent obtained in this study is less than that of the international reference value of 370 Bq/kg for the both kind of tiles.

SUBMITTER: Joel ES

PROVIDER: S-EPMC5789825 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Comparative Analysis of Natural Radioactivity Content in Tiles made in Nigeria and Imported Tiles from China.

Joel E S ES Maxwell O O Adewoyin O O OO Ehi-Eromosele C O CO Saeed M A MA

Scientific reports 20180130 1

In this investigation, natural radioactive contents in tiles manufactured in Nigeria and tiles imported from China were measured using gamma ray spectroscopy. High Purity Germanium detector was used to estimate the concentrations of some radioisotopes present in 17 samples of various tiles from Nigeria and China. The average activity concentrations of 226Ra, 232Th, and 40K for the tiles were found to be 68.2 ± 0.5; 173.9 ± 9.2 and 490 ± 15 Bq/kg and 58.2 ± 0.5, 1 ...[more]

PMID: 29382885

Similar Datasets

Project description:BackgroundTo investigate the antimicrobial profiles and genomic characteristics of MDR-Citrobacter spp. strains isolated from Fennec fox imported from Sudan to China.MethodsFour Citrobacter spp. strains were isolated from stool samples. Individual fresh stool samples were collected and subsequently diluted in phosphate buffered saline as described previously. The diluted fecal samples were plated on MacConkey agar supplemented with 1 mg/l cefotaxime and incubated for 20 h at 37 °C. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) was used for identification. Antimicrobial susceptibility testing was performed using the broth microdilution method. Whole-genome sequencing was performed on an Illumina Novaseq-6000 platform. Acquired antimicrobial resistance genes and plasmid replicons were detected using ResFinder 4.1 and PlasmidFinder 1.3, respectively. Comparative genomic analysis of 277 Citrobacter genomes was also performed.ResultsIsolate FF141 was identified as Citrobacter cronae while isolate FF371, isolate FF414, and isolate FF423 were identified as Citrobacter braakii. Of these, three C. braakii isolates were further confirmed to be extended-spectrum β-lactamases (ESBL)-producer. All isolates are all multidrug resistance (MDR) with resistance to multiple antimicrobials. Plasmid of pKPC-CAV1321 belong to incompatibility (Inc) group. Comparative genomics analysis of Citrobacter isolates generated a large core-genome. Genetic diversity was observed in our bacterial collection, which clustered into five main clades. Human, environmental and animal Citrobacter isolates were distributed into five clusters.ConclusionsTo our knowledge, this is the first investigation of MDR-Citrobacter from Fennec Fox. Our phenotypic and genomic data further underscore the threat of increased ESBL prevalence in wildlife and emphasize that increased effort should be committed to monitoring the potentially rapid dissemination of ESBL-producers with one health perspective.

Project description:BackgroundAffordability to novel anticancer drugs has become a major health issue in China. It is encouraging to note that China initiated its drug regulatory reform and national price negotiation policies since 2015. As a growing number of domestic within-class targeted anticancer drugs are approved in China, it is expected that this may reduce the price of novel anticancer drugs and improve the affordability of anticancer drugs. This study aimed to evaluate the price, efficacy, and safety of the within-class anticancer drugs between domestic and imported drugs approved in China from 2010 to 2022.MethodsThe domestic and imported within-class targeted drugs for solid cancers approved in China between 2010 and 2022 were extracted. We classified it as a class of anticancer drugs based on the same indication and similar biological mechanism. The published literature derived from pivotal clinical trials of these domestic and imported drugs was identified based on the review report and the latest labels issued by the China National Medical Products Administration. We evaluated the monthly treatment price at launch and the latest (2022), primary efficacy endpoint and safety between domestic and imported anticancer drugs. Meta-analyses were further employed to evaluate the efficacy and safety of the domestic and imported anticancer drugs, including pooled hazard ratios (HR) for progression-free survival (PFS), overall survival (OS), objective response rates (ORR) for solid cancers, and relative risk for serious adverse events (SAE) and Grade ≥3 adverse events (AEs).FindingsIn our cohort study, 12 within-class anticancer drugs with 7 cancer diseases were analyzed, including 18 domestic (21 indications; 21 pivotal trials) and 18 imported (21 indications; 27 pivotal trials) novel anticancer drugs, respectively. The median monthly treatment price of domestic and imported drugs from the years of launch to 2022 had significantly decreased by 71% and 62%, respectively. Moreover, the median monthly treatment price of domestic targeted anticancer drugs on the market at launch ($3786 vs. $5393, P = 0.007) and the latest ($1222 vs. $2077, P = 0.011) was significantly lower than that of imported drugs. No significant differences in median PFS gains (9.0 vs. 11.0 months; P = 0.24), OS gains (9.3 vs 10.6 months; P = 0.66), and ORR (57% vs 62%, P = 0.77) of targeted anticancer drugs in their pivotal trials were observed between the domestic and imported drugs. Additionally, there was no significant difference between domestic and imported drugs in the incidence of SAE (23% vs. 24%; P = 0.41) and Grade ≥3 AEs (59% vs. 57%; P = 0.45). These findings were also further confirmed in the meta-analyses for primary efficacy endpoints and safety outcomes.InterpretationThe prices of both domestic and imported anticancer drugs significantly decreased after market entry mainly due to the role of national price negotiations. The median monthly treatment price of domestic within-class targeted anticancer drugs was significantly lower than that of imported drugs. Furthermore, the efficacy and safety of domestic anticancer drugs were comparable to that of imported drugs. This evidence implicated that the development of within-class anticancer drugs with national price negotiations in China significantly improved the affordability for patients.FundingThis study was supported by postdoctoral fellowship from Tsinghua-Peking Joint Centers for Life Sciences (CLS).

Project description:Funding institutions often solicit text-based research proposals to evaluate potential recipients. Leveraging the information contained in these documents could help institutions understand the supply of research within their domain. In this work, an end-to-end methodology for semi-supervised document clustering is introduced to partially automate classification of research proposals based on thematic areas of interest. The methodology consists of three stages: (1) manual annotation of a document sample; (2) semi-supervised clustering of documents; (3) evaluation of cluster results using quantitative metrics and qualitative ratings (coherence, relevance, distinctiveness) by experts. The methodology is described in detail to encourage replication and is demonstrated on a real-world data set. This demonstration sought to categorize proposals submitted to the US Army Telemedicine and Advanced Technology Research Center (TATRC) related to technological innovations in military medicine. A comparative analysis of method features was performed, including unsupervised vs. semi-supervised clustering, several document vectorization techniques, and several cluster result selection strategies. Outcomes suggest that pretrained Bidirectional Encoder Representations from Transformers (BERT) embeddings were better suited for the task than older text embedding techniques. When comparing expert ratings between algorithms, semi-supervised clustering produced coherence ratings ~ 25% better on average compared to standard unsupervised clustering with negligible differences in cluster distinctiveness. Last, it was shown that a cluster result selection strategy that balances internal and external validity produced ideal results. With further refinement, this methodological framework shows promise as a useful analytical tool for institutions to unlock hidden insights from untapped archives and similar administrative document repositories.Supplementary informationThe online version contains supplementary material available at 10.1007/s11192-023-04689-3.

Dataset Information

Comparative Analysis of Natural Radioactivity Content in Tiles made in Nigeria and Imported Tiles from China.

Publications

Comparative Analysis of Natural Radioactivity Content in Tiles made in Nigeria and Imported Tiles from China.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets